HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells - Concepedia

Concepedia

Publication | Open Access

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells

DOI Full Paper Access

17

Citations

38

References

2022

Year

Qiang Qiu, Linyu Yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui,

Bioactive Materials

References

	Year	Citations

Page 1